Publications by authors named "Brooke Sanders"

Claim this Profile
T
Targeting RAD52 overcomes PARP inhibitor resistance in preclinical -deficient ovarian cancer model.
Yukihide Ota, Vijayalaxmi Gupta, Bisiayo E Fashemi, Moreniola Akande, Preedia Babu, Brooke Sanders

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms.
Elena Lomonosova, Megan Loeb, Kevin Rodriguez, Lilian N van Biljon, Joshua Brill, Brooke Sanders

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
Angela Schab, Amanda Compadre, Rebecca Drexler, Megan Loeb, Kevin Rodriguez, Brooke Sanders

J Clin Invest· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
Angela Schab, Amanda Compadre, Rikki Drexler, Maggie Loeb, Kevin Rodriguez, Brooke Sanders

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A toolkit for a modern gynecologic oncology tissue bank.
Olivia Graham, Jeimmy Rodriguez, Rachel Abbott, Elena Lomonosova, Bisiayo Fashemi, Brooke Sanders

Gynecol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
pneumonia complicating methotrexate treatment in a patient with low-risk post-molar gestational trophoblastic neoplasia: A case report and review of the literature.
Hector S Porragas-Paseiro, Steven Johnson, Lindsay Brubaker, Brooke E Sanders

Gynecol Oncol Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.
Alexandra McMellen, Tomomi M Yamamoto, Lubna Qamar, Brooke E Sanders, Lily L Nguyen

Mol Cancer Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous Retrovirus RNA Expression Differences between Race, Stage and HPV Status Offer Improved Prognostication among Women with Cervical Cancer.
Jill Alldredge, Vinay Kumar, James Nguyen, Brooke E Sanders, Karina Gomez

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): A review and novel case with dual germline SMARCA4 and BRCA2 mutations.
Brooke E Sanders, Rebecca Wolsky, Elizabeth S Doughty, Kristen L Wells, Debashis Ghosh

Gynecol Oncol Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian Carcinoma.
Brooke E Sanders, Tomomi M Yamamoto, Alexandra McMellen, Elizabeth R Woodruff, Amber Berning

Mol Cancer Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of blinding interviewers to written applications on ranking of Gynecologic Oncology fellowship applicants from groups underrepresented in medicine.
Jennifer Haag, Brooke E Sanders, Joseph Walker Keach, Carolyn Lefkowits, Jeanelle Sheeder

Gynecol Oncol Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Genetic Variants in Matched Biocompartments From Patients With Serous Ovarian Cancer.
Brooke E Sanders, Lisa Ku, Paul Walker, Benjamin G Bitler

Technol Cancer Res Treat· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.
Brooke E Sanders, Samah Saharti, Katharina Laus, Robert E Bristow, Ramez N Eskander

J Obstet Gynaecol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship status and other demographic influences on survival in patients with ovarian cancer.
Austin B Gardner, Brooke E Sanders, Amandeep K Mann, Cheng-I Liao, Ramez Nassef Eskander

Int J Gynecol Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Didactic Methods for Training Medical Students in the Use of Bedside Ultrasound for Clinical Practice at a Faculty of Medicine in Romania.
Cosmin C Florescu, Jeffrey A Mullen, Vivian My Nguyen, Brooke E Sanders, Priscilla Quynh-Phuon Vu

J Ultrasound Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis